(FM) Inmunología
Departamento académico
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (2)
2021
-
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Nature Genetics, Vol. 53, Núm. 11, pp. 1606-1615
2010
-
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009
Cancer Immunology, Immunotherapy